TrialCancer discovery2017

A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors.

Alexander Drilon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.